Bayer Sues Hexal, Salutas Over Heartburn Pill Patents
Bayer Consumer AG filed its lawsuit in the District Court of Dusseldorf, over the sale of Omep Hexal 20 milligram tablets, which are a generic product of Hexal, according to Bayer.
In July 2009, Bayer Vital — Bayer’s German marketing organization — said it had received a license from AstraZeneca PLC for the marketing of over-the-counter...
Already a subscriber? Click here to login